12:00 AM
Feb 23, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ondansetron RapidFilm regulatory update

BioAlliance submitted an MAA to EMEA for ondansetron RapidFilm to prevent chemotherapy- and radiation-induced nausea and vomiting. The company made...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >